Skip to content
value.today

Veru Inc.: valuation

What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.

Cash-flow value

Free cash flow over the last three years averaged below zero, so a cash-flow value cannot be worked out.

Price to bookPrice to book of Biotechnology: $56 M to $236 M, median $82 M$0 M$64 M$128 M$191 M$255 MMarket value $41 M

Your own DCF model

A full discounted-cash-flow model of Veru Inc., started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.

Open the DCF model

Against the industry Biotechnology

Multiples of its companies with a market value at most 60 days old, times Veru Inc.'s own figures of FY2025.

Values from the peers' multiples
MultiplePeers (25th / median / 75th)Veru Inc.Applied toValue (25th to 75th)Companies
Price to book3.1× / 4.5× / 12.9×2.3×book equity $18 M$56 M to $236 M69

Against its own history

Veru Inc.'s multiples at each month end with a market cap on file, Jan 2020 to Oct 2026, each against its own median.

Price to sales

5.0×

Now below its median of 6.3×, in the bottom quarter of its range; range 2.8× to 14.1× over 9 months.

0×4×7×11×14×202020212022202320242025Price to sales 5×Median 6×

Price to book

2.3×

Now below its median of 2.3×; range 1.1× to 19.9× over 30 months.

0×5×10×15×20×2020202120222023202420252026Price to book 2×Median 2×

As of Oct 9, 2026

The statements it starts from

USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.

Figures from the annual statements
Fiscal yearRevenueNet incomeCash from operationsCapital spendingFree cash flowNet debtSource
FY2025to Sep 30, 2025—$-23 M$-30 M$0 M$-30 M—SEC annual report (10-K, 20-F)
FY2024to Sep 30, 2024$17 M$-38 M$-22 M$0 M$-22 M—SEC annual report (10-K, 20-F)
FY2023to Sep 30, 2023$16 M$-93 M$-88 M$1 M$-89 M—SEC annual report (10-K, 20-F)
FY2022to Sep 30, 2022$39 M$-84 M$-48 M$1 M$-48 M—SEC annual report (10-K, 20-F)
FY2021to Sep 30, 2021$61 M$7 M$-16 M$0 M$-16 M—SEC annual report (10-K, 20-F)
FY2020to Sep 30, 2020$43 M$-19 M$-2 M$0 M$-2 M—SEC annual report (10-K, 20-F)